Capital Bank & Trust CO Agios Pharmaceuticals, Inc. Transaction History

Capital Bank & Trust CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $86,262 - $133,913	-2,504 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $621,921 - $1.06 Million	-19,731 Reduced 88.74%	2,504 $89,000
Q4 2019 Feb 18, 2020	SELL	$30.08 - $50.59 $6.73 Million - $11.3 Million	-223,724 Reduced 90.96%	22,235 $1.06 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $154,386 - $236,248	-4,765 Reduced 1.9%	245,959 $7.97 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $24,470 - $36,093	530 Added 0.21%	250,724 $12.5 Million
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $6.64 Million - $9.78 Million	144,592 Added 136.92%	250,194 $16.9 Million
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $5.67 Million - $10.2 Million	-132,653 Reduced 55.68%	105,602 $4.87 Million
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $209,276 - $268,494	-2,920 Reduced 1.21%	238,255 $18.4 Million
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $290,463 - $394,914	3,967 Added 1.67%	241,175 $20.3 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $7.67 Million - $11.1 Million	128,148 Added 117.5%	237,208 $19.4 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $632,476 - $877,724	-12,135 Reduced 10.01%	109,060 $6.24 Million
Q3 2017 Nov 14, 2017	SELL	$54.89 - $67.12 $77,394 - $94,639	-1,410 Reduced 1.15%	121,195 $8.09 Million
Q2 2017 Aug 14, 2017	BUY	N/A	122,605	122,605 $6.31 Million

243

58.3M

431K

309K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.82B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.